Haemodynamic effects of patent foramen ovale and atrial septal defect closure: a comparison during percutaneous shunt closure

被引:4
|
作者
Luermans, Justin G. L. M. [1 ]
Bos, Willem J. W. [2 ]
Post, Martijn C. [1 ]
ten Berg, Jurrien M. [1 ]
Plokker, H. W. Thijs [1 ]
Suttorp, Maarten J. [1 ]
机构
[1] St Antonius Hosp, Dept Cardiol, NL-3435 CM Nieuwegein, Netherlands
[2] St Antonius Hosp, Dept Internal Med, NL-3435 CM Nieuwegein, Netherlands
关键词
atrial septal defect; Finometer; haemodynamics; patent foramen ovale; transcatheter closure; TRANSCATHETER CLOSURE; ARTERIAL-PRESSURE; FINGER; HUMANS; FLOW;
D O I
10.1111/j.1475-097X.2009.00905.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
P>Objectives: We investigated the haemodynamic effect of percutaneous closure of an intra-atrial shunt, using non-invasive finger pressure measurements. Background: Percutaneous closure of both patent foramen ovale (PFO) and atrial septal defect (ASD) is widely practised. Currently no data are available on short-term haemodynamic changes induced by closure. Methods: Twenty-five consecutive patients (mean age 49 +/- 17 years, 10 men) who underwent a percutaneous closure of a PFO (n = 15) or ASD (n = 10) were included in this study. During the procedure blood pressure and heart rate (HR) were monitored continuously with a Finometer (R). Changes in systolic, mean, and diastolic pressure, stroke volume (SV), cardiac output (CO) and total peripheral resistance (TPR) were computed from the pressure registrations using Modelflow (R) methodology. Results: Baseline characteristics were similar for the PFO and ASD patients. After PFO closure none of the haemodynamic parameters changed significantly. After ASD closure the systolic, mean, and diastolic pressures increased 7 center dot 1 +/- 5 center dot 4 (P = 0 center dot 003), 3 center dot 8 +/- 3 center dot 5 (P = 0 center dot 007) and 2 center dot 0 +/- 3 center dot 0 mmHg (P = ns) respectively. HR decreased 5 center dot 1 +/- 5 center dot 3 beats per minute (P = 0 center dot 01). SV, CO and TPR increased 8 center dot 5 +/- 6 center dot 4 ml (13 center dot 5%; P = 0 center dot 002), 0 center dot 21 +/- 0 center dot 45 l min-1 (5 center dot 6%; P = ns) and 0 center dot 02 +/- 0 center dot 14 dynes (4 center dot 1%; P = ns) respectively. The changes in SV differ between the PFO and ASD patients (P = 0 center dot 009). Conclusions: Using non-invasive finger pressure measurements, we found that SV, mean and systolic blood pressure increased immediately after percutaneous closure of an ASD in adults, whereas the percutaneous PFO closure had no effect on haemodynamic characteristics.
引用
收藏
页码:64 / 68
页数:5
相关论文
共 50 条
  • [1] Percutaneous closure of patent foramen ovale and atrial septal defect - Reply
    Opotowsky, Alexander R.
    Landzberg, Michael J.
    Webb, Gary D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (19): : 2272 - 2273
  • [2] Intracardiac echocardiographr during percutaneous closure of atrial septal defect and patent foramen ovale
    Brochet, E
    Habib, G
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2005, 98 : 25 - 28
  • [3] PERCUTANEOUS PATENT FORAMEN OVALE OR ATRIAL SEPTAL DEFECT CLOSURE IN IMMUNOCOMPROMISED PATIENTS
    Kar, Subrata
    Aboulhosn, Jamil
    Tandar, Anwar
    Gevorgyan, Rubine
    Miller, Nicholas
    Tobis, Jonathan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A527 - A527
  • [4] Echocardiographic Assessment of Percutaneous Patent Foramen Ovale and Atrial Septal Defect Closure Complications
    Yared, Kibar
    Baggish, Aaron L.
    Solis, Jorge
    Durst, Ronen
    Passeri, Jonathan J.
    Palacios, Igor F.
    Picard, Michael H.
    CIRCULATION-CARDIOVASCULAR IMAGING, 2009, 2 (02) : 141 - 149
  • [5] Nonsurgical closure of secundum atrial septal defect and patent foramen ovale
    Chatterjee, T
    Aeschbacher, BC
    Meier, B
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 127 (49) : 2054 - 2060
  • [6] Patent foramen ovale and ventricular septal defect closure
    Wahl, A.
    Meier, B.
    HEART, 2009, 95 (01) : 70 - 82
  • [7] Percutaneous Closure of Interatrial Septal Abnormalities (Patent Foramen Ovale and Atrial Septal Defect) for Prevention of Paradoxical Embolism
    Fu, Qiang
    Guo, Caixia
    Chen, Buxing
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (16) : S44 - S45
  • [8] Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation
    Loar, Robert W.
    Johnson, Jonathan N.
    Cabalka, Allison K.
    Cetta, Frank
    Hagler, Donald J.
    Eidem, Benjamin W.
    Taggart, Nathaniel W.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (07) : 1234 - 1237
  • [9] Percutaneous Patent Foramen Ovale/Atrial Septal Defect Closure: Just Because We Can? Reply
    Karamlou, Tara
    Diggs, Brian S.
    McCrindle, Brian W.
    Ungerleider, Ross M.
    Welke, Karl F.
    ANNALS OF THORACIC SURGERY, 2009, 88 (04): : 1386 - 1387
  • [10] Electrocardiographic Changes and Arrhythmias Following Percutaneous Atrial Septal Defect and Patent Foramen Ovale Device Closure
    Johnson, Jonathan N.
    Marquardt, Michelle L.
    Ackerman, Michael J.
    Asirvatham, Samuel J.
    Reeder, Guy S.
    Cabalka, Allison K.
    Cetta, Frank
    Hagler, Donald J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2011, 78 (02) : 254 - 261